US › Healthcare

India Globalization Capital Inc (IGC)

US · Healthcare · Biotechnology

$0.25+1.18%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$317,000

Revenue YoY

-3.9%

Net profit

$-2.4M

Profit YoY

-100.7%

EPS

$-0.02

EPS estimate

$-0.02

Net margin

-757.7%

EPS came in at -0.02 against a street estimate of -0.02 — a beat of 0.0%.

Key statistics

Market cap

$25.6M

Forward P/E

0.0

P/B

4.25

Book value

$0.06

EPS (TTM)

$-0.06

52-week high

$0.50

52-week low

$0.24

50-day MA

$0.28

200-day MA

$0.30

Beta

0.46

Analyst view

Analysts rate India Globalization Capital Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $4.25.

Shareholding

Insiders

13.38%

Institutions

21.70%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for India Globalization Capital Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.